← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #620 OF 1,000 MOST-CITED

Written procedures followed

FDA cited this observation 28 times across 28 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs28
BY FISCAL YEAR
FY20253
FY20232
FY20223
FY20204
FY20195
FY201810
FY20171

How FDA worded it — real examples

Procedures for the preparation of master production and control records are not followed.

Simtra Deutschland GmbH · Halle (Westf.) · Drugs · 2025-09-26

Procedures for the preparation of master production and control records are not described in a written procedure.

Fareva Amboise · Poce Sur Cisse · Drugs · 2025-09-16

Procedures for the preparation of master production and control records are not described in a written procedure.

Americanna Wellness Incorporated · Bellingham, Washington · Drugs · 2024-10-28

Procedures for the preparation of master production and control records are not followed.

Baxter Pharmaceuticals India Pvt Ltd · Ahmedabad · Drugs · 2023-01-27

Procedures for the preparation of master production and control records are not described in a written procedure and followed.

Purechempros LLC · Tempe, Arizona · Drugs · 2022-11-22

Procedures for the preparation of master production and control records are not followed.

Glenmark Pharmaceuticals Inc USA · Monroe, North Carolina · Drugs · 2022-05-19

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →